lobbying_activities: 3001057

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3001057	ffed5c3e-820a-472c-ad0e-038bf7ee27e0	Q2	KING & SPALDING LLP	21632	KANEKA PHARMA AMERICA, LLC	2023	second_quarter	MMM	Advocacy in support of Medicare coverage for Dialysis-Related Amyloidosis (DRA) Treatment.	Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE	30000		0	0	2023-07-11T15:18:52-04:00